CA2271796A1 - Oral compositions containing fluoride, pyrophosphate, and peroxide - Google Patents
Oral compositions containing fluoride, pyrophosphate, and peroxide Download PDFInfo
- Publication number
- CA2271796A1 CA2271796A1 CA002271796A CA2271796A CA2271796A1 CA 2271796 A1 CA2271796 A1 CA 2271796A1 CA 002271796 A CA002271796 A CA 002271796A CA 2271796 A CA2271796 A CA 2271796A CA 2271796 A1 CA2271796 A1 CA 2271796A1
- Authority
- CA
- Canada
- Prior art keywords
- oral composition
- pyrophosphate
- calcium peroxide
- mixture
- tetrasodium pyrophosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 177
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 title claims abstract description 27
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 title claims description 24
- 235000011180 diphosphates Nutrition 0.000 title claims description 19
- 150000002978 peroxides Chemical class 0.000 title description 20
- 239000004343 Calcium peroxide Substances 0.000 claims abstract description 39
- -1 alkali metal bicarbonate salt Chemical class 0.000 claims abstract description 39
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 claims abstract description 39
- 235000019402 calcium peroxide Nutrition 0.000 claims abstract description 39
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims abstract description 27
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000811 xylitol Substances 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 15
- 235000010447 xylitol Nutrition 0.000 claims abstract description 15
- 229960002675 xylitol Drugs 0.000 claims abstract description 15
- 239000008365 aqueous carrier Substances 0.000 claims abstract description 12
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 10
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical group [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 18
- 239000011775 sodium fluoride Substances 0.000 claims description 11
- 235000013024 sodium fluoride Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 42
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 28
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 26
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 20
- 239000000377 silicon dioxide Substances 0.000 description 20
- 239000000606 toothpaste Substances 0.000 description 19
- 239000011734 sodium Substances 0.000 description 17
- 229910052708 sodium Inorganic materials 0.000 description 17
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- 229940091249 fluoride supplement Drugs 0.000 description 16
- 229920001223 polyethylene glycol Polymers 0.000 description 16
- 229940034610 toothpaste Drugs 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 14
- 235000019634 flavors Nutrition 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 239000000551 dentifrice Substances 0.000 description 13
- 239000004408 titanium dioxide Substances 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000002562 thickening agent Substances 0.000 description 11
- 208000006558 Dental Calculus Diseases 0.000 description 10
- 239000002202 Polyethylene glycol Substances 0.000 description 10
- 239000001768 carboxy methyl cellulose Substances 0.000 description 10
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 description 10
- 235000017550 sodium carbonate Nutrition 0.000 description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 9
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 239000000230 xanthan gum Substances 0.000 description 9
- 235000010493 xanthan gum Nutrition 0.000 description 9
- 229920001285 xanthan gum Polymers 0.000 description 9
- 229940082509 xanthan gum Drugs 0.000 description 9
- 239000003906 humectant Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 150000003839 salts Chemical group 0.000 description 7
- 239000006172 buffering agent Substances 0.000 description 6
- 239000006072 paste Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 5
- 239000003082 abrasive agent Substances 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 238000005498 polishing Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 229920001983 poloxamer Polymers 0.000 description 3
- 229920001992 poloxamer 407 Polymers 0.000 description 3
- 229940044476 poloxamer 407 Drugs 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229960000502 poloxamer Drugs 0.000 description 2
- 229940045916 polymetaphosphate Drugs 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PXLKJWMSFPYVNB-UHFFFAOYSA-N (1-methyl-4-propan-2-ylcyclohexyl) acetate Chemical compound CC(C)C1CCC(C)(OC(C)=O)CC1 PXLKJWMSFPYVNB-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- RMSOEGBYNWXXBG-UHFFFAOYSA-N 1-chloronaphthalen-2-ol Chemical compound C1=CC=CC2=C(Cl)C(O)=CC=C21 RMSOEGBYNWXXBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RADIRXJQODWKGQ-HWKANZROSA-N 2-Ethoxy-5-(1-propenyl)phenol Chemical compound CCOC1=CC=C(\C=C\C)C=C1O RADIRXJQODWKGQ-HWKANZROSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 229930182827 D-tryptophan Natural products 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- SOWBFZRMHSNYGE-UHFFFAOYSA-N Monoamide-Oxalic acid Natural products NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- VCHVXUQQZMQWIY-UHFFFAOYSA-N [AlH3].[Mg].[Li] Chemical compound [AlH3].[Mg].[Li] VCHVXUQQZMQWIY-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000003610 anti-gingivitis Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 150000004691 decahydrates Chemical group 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 1
- QPXWUAQRJLSJRT-UHFFFAOYSA-N diethoxyphosphinothioyl diethyl phosphate Chemical compound CCOP(=O)(OCC)OP(=S)(OCC)OCC QPXWUAQRJLSJRT-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 239000001902 eugenia caryophyllata l. bud oil Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical group [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000010663 parsley oil Substances 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229940048106 sodium lauroyl isethionate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- VZWGHDYJGOMEKT-UHFFFAOYSA-J sodium pyrophosphate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O VZWGHDYJGOMEKT-UHFFFAOYSA-J 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- BRMSVEGRHOZCAM-UHFFFAOYSA-M sodium;2-dodecanoyloxyethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OCCS([O-])(=O)=O BRMSVEGRHOZCAM-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- VVGOCOMZRGWHPI-UHFFFAOYSA-N trans-hept-4-enal Natural products CCC=CCCC=O VVGOCOMZRGWHPI-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- VSJRDSLPNMGNFG-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VSJRDSLPNMGNFG-UHFFFAOYSA-H 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 229940085658 zinc citrate trihydrate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to an oral composition comprising a soluble fluoride ion source, tetrasodium pyrophosphate, calcium peroxide, and one or more aqueous carriers, wherein the oral composition has a neat pH of from about 9.0 to about 10.5 and a total water content of from about 9.1 % to about 20 %. The invention may also include an alkali metal bicarbonate salt and xylitol.
Description
ORAL COMPOSITIONS CONTAINING FLUORIDE, PYROPHOSPHATE, AND PEROXIDE
s BACKGROUND OF THE IIWENTION
The present invention relates to stable oral compositions containing fluoride, pyrophosphate, and calcium peroxide, wherein the total water content and pH
are t o controlled.
Oral compositions utilizing a peroxide component are known. The most widely used peroxide has been hydrogen peroxide. Compositions containing peroxide generally deliver benefits in the antiplaque and antigingivitis areas. Other cosmetic benefits, such as tooth whitening, may also be provided. Oral compositions formulated t s with peroxide, a highly reactive ingredient, generally exhibit poor stability and many products do not have consumer preferred aesthetics.
While peroxide executions have been developed, they present a processing and stability challenge. Producing stable peroxide compositions also containing tartar control ingredients and fluoride in the same phase is even more difficult. It is difficult 2o to stabilize the peroxide in the presence of fluoride and tartar control ingredients, without producing a product which has negative aesthetics and tartar control efficacy concerns.
References disclosing peroxide containing compositions include U.S. Patent 5,403,578, to Norman, issued April 4, 1995, which discloses an oral composition 2s containing peroxide, a tartar control ingredient, and fluoride. To stabilize the peroxide, the peroxide is microencapsulated to avoid the peroxide reacting with the other ingredients. U.S. Patents 5,456,902, to Williams, et al., issued October 10, 1995, and 5,372,803, to Williams, et al., issued December 13, 1994, disclose a composition utilizing a dual-compartment dispenser which separates the peroxide phase from the 3o tartar control ingredients. WO 95/09b03, published April 13, 1995, also discloses a dual-compartment container which separates a calcium peroxide phase from the other dentifrice phase.
' Canadian published applications 2.162,82l, 2,162,885, and 2,162,8I2, all published May 15, 1996, disclose the use of calcium peroxide in a dentifrice.
The 3s amount of the water is controlled in these applications to aid in the stability.
Although peroxide products containing tartar control ingredients and fluoride are known, there is a continuing need to develop improved products. The present inventors WO 98I23248 PCT/US97t21151 have discovered that a stable oral composition can be formulated to include a soluble fluoride ion source, pyrophosphate, and calcium peroxide by controlling the total water content and the pH. It has also been discovered that these oral compositions may also contain an alkali metal bicarbonate salt and xylitol while still maintaining good s stability.
It is therefore an object of the present invention to provide a stable tartar control composition that contains a soluble fluoride ion source and calcium peroxide.
It is also an object of the present invention to provide a tartar control composition that contains a soluble fluoride ion source, calcium peroxide, an alkali metal bicarbonate salt, and i o xylitol. A further object of the present invention is to provide compositions which deliver a variety of benefits to the mouth, such as those described above, and compositions having improved aesthetics.
These and other objects of the present invention will become readily apparent from the detailed description which follows.
t s A11 percentages and ratios used herein are by weight of the total composition, and a11 measurements are made at 25°C, unless otherwise specified.
SUMMARY OF THE INVENTION
The present invention relates to an oral composition comprising a soluble fluoride ion source capable of providing from about 50 ppm to about 3500 ppm of free 2o fluoride ions, an amount of at least about 1.5% tetrasodium pyrophosphate, from about 0.01% to about 5% of calcium peroxide, and from about 80% to about 98% of one or more aqueous carriers, wherein the oral composition has a neat pH of from about 9.0 to about 10.5 and a total water content of from about 9.1 % to about 20%. The invention may also include from about 0.5% to about 40% of an alkali metal bicarbonate salt and 2s from about 0.01% to about 25% of xylitol.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to oral compositions comprising fluoride, tetrasodium pyrophosphate, and calcium peroxide. These compositions can also include an alkali metal bicarbonate salt and xylitol.
3o The oral compositions of the present invention may be in the form of a toothpaste. The term "toothpaste", as used herein, means paste, gel, or liquid formulations unless otherwise specified. The toothpaste may be in any desired form, such as deep striped, surface striped, mulitlayered, having the gel surrounding the paste, or any combination thereof. The toothpaste may also be a multilayer composition 3s which is extruded from the tube in combination paste/gel stripes. One of the layers must comprise all of the essential components, while the other layers may contain less than a11 of the essential components or may be any dentifrice formulation.
The term "oral composition" as used herein means a product which in the ordinary course of usage is not intentionally swallowed for purposes of systemic s administration of particular therapeutic agents, but is rather retained in the oral cavity " for a time sufficient to contact substantially all of the dental surfaces and/or oral tissues for purposes of oral activity.
The term "aqueous carrier" as used herein means any safe and effective materials for use in the compositions of the present invention. Such materials include thickening i o materials, humectants, water, buffering agents, abrasive polishing materials, surfactants, titanium dioxide, flavor system, sweetening agents, coloring agents, and mixtures thereof.
The present compositions comprise essential components, as well as optional components. The essential and optional components of the compositions of the present ~ s invention are described in the following paragraphs.
Fluoride Ion Source The present invention incorporates a soluble fluoride source capable of providing free fluoride ions. Preferred soluble fluoride ion sources include sodium fluoride, stannous fluoride, indium fluoride, and sodium monofluorophosphate.
Sodium zo fluoride is the most preferred soluble fluoride ion source. Norris et al., U.S. Patent 2,946,725, issued July 26, 1960, and Widder et al., U. S. Patent 3,678,154 issued July 18, 1972, disclose such fluoride ion sources as well as others. Both patents are incorporated herein by reference in their entirety.
The present compositions contain a soluble fluoride source capable of providing zs from about 50 ppm to about 3500 ppm, and preferably from about 500 ppm to about 3000 ppm of free fluoride ions.
Pyrophos~hate source The present invention also includes a pyrophosphate source. The pyrophosphate source comprises predominately undissolved pyrophosphate. Undissolved 3o pyrophosphate compositions are defined as compositions containing no more than about 20% of the total pyrophosphate salt dissolved in the composition, preferably less than ~ about 10% of the total pyrophosphate dissolved in the composition.
Tetrasodium pyrophosphate salt is the preferred pyrophosphate salt in these compositions.
It is also preferred that tetrasodium pyrophosphate be the only pyrophosphate or tartar control 3s agent used.
s BACKGROUND OF THE IIWENTION
The present invention relates to stable oral compositions containing fluoride, pyrophosphate, and calcium peroxide, wherein the total water content and pH
are t o controlled.
Oral compositions utilizing a peroxide component are known. The most widely used peroxide has been hydrogen peroxide. Compositions containing peroxide generally deliver benefits in the antiplaque and antigingivitis areas. Other cosmetic benefits, such as tooth whitening, may also be provided. Oral compositions formulated t s with peroxide, a highly reactive ingredient, generally exhibit poor stability and many products do not have consumer preferred aesthetics.
While peroxide executions have been developed, they present a processing and stability challenge. Producing stable peroxide compositions also containing tartar control ingredients and fluoride in the same phase is even more difficult. It is difficult 2o to stabilize the peroxide in the presence of fluoride and tartar control ingredients, without producing a product which has negative aesthetics and tartar control efficacy concerns.
References disclosing peroxide containing compositions include U.S. Patent 5,403,578, to Norman, issued April 4, 1995, which discloses an oral composition 2s containing peroxide, a tartar control ingredient, and fluoride. To stabilize the peroxide, the peroxide is microencapsulated to avoid the peroxide reacting with the other ingredients. U.S. Patents 5,456,902, to Williams, et al., issued October 10, 1995, and 5,372,803, to Williams, et al., issued December 13, 1994, disclose a composition utilizing a dual-compartment dispenser which separates the peroxide phase from the 3o tartar control ingredients. WO 95/09b03, published April 13, 1995, also discloses a dual-compartment container which separates a calcium peroxide phase from the other dentifrice phase.
' Canadian published applications 2.162,82l, 2,162,885, and 2,162,8I2, all published May 15, 1996, disclose the use of calcium peroxide in a dentifrice.
The 3s amount of the water is controlled in these applications to aid in the stability.
Although peroxide products containing tartar control ingredients and fluoride are known, there is a continuing need to develop improved products. The present inventors WO 98I23248 PCT/US97t21151 have discovered that a stable oral composition can be formulated to include a soluble fluoride ion source, pyrophosphate, and calcium peroxide by controlling the total water content and the pH. It has also been discovered that these oral compositions may also contain an alkali metal bicarbonate salt and xylitol while still maintaining good s stability.
It is therefore an object of the present invention to provide a stable tartar control composition that contains a soluble fluoride ion source and calcium peroxide.
It is also an object of the present invention to provide a tartar control composition that contains a soluble fluoride ion source, calcium peroxide, an alkali metal bicarbonate salt, and i o xylitol. A further object of the present invention is to provide compositions which deliver a variety of benefits to the mouth, such as those described above, and compositions having improved aesthetics.
These and other objects of the present invention will become readily apparent from the detailed description which follows.
t s A11 percentages and ratios used herein are by weight of the total composition, and a11 measurements are made at 25°C, unless otherwise specified.
SUMMARY OF THE INVENTION
The present invention relates to an oral composition comprising a soluble fluoride ion source capable of providing from about 50 ppm to about 3500 ppm of free 2o fluoride ions, an amount of at least about 1.5% tetrasodium pyrophosphate, from about 0.01% to about 5% of calcium peroxide, and from about 80% to about 98% of one or more aqueous carriers, wherein the oral composition has a neat pH of from about 9.0 to about 10.5 and a total water content of from about 9.1 % to about 20%. The invention may also include from about 0.5% to about 40% of an alkali metal bicarbonate salt and 2s from about 0.01% to about 25% of xylitol.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to oral compositions comprising fluoride, tetrasodium pyrophosphate, and calcium peroxide. These compositions can also include an alkali metal bicarbonate salt and xylitol.
3o The oral compositions of the present invention may be in the form of a toothpaste. The term "toothpaste", as used herein, means paste, gel, or liquid formulations unless otherwise specified. The toothpaste may be in any desired form, such as deep striped, surface striped, mulitlayered, having the gel surrounding the paste, or any combination thereof. The toothpaste may also be a multilayer composition 3s which is extruded from the tube in combination paste/gel stripes. One of the layers must comprise all of the essential components, while the other layers may contain less than a11 of the essential components or may be any dentifrice formulation.
The term "oral composition" as used herein means a product which in the ordinary course of usage is not intentionally swallowed for purposes of systemic s administration of particular therapeutic agents, but is rather retained in the oral cavity " for a time sufficient to contact substantially all of the dental surfaces and/or oral tissues for purposes of oral activity.
The term "aqueous carrier" as used herein means any safe and effective materials for use in the compositions of the present invention. Such materials include thickening i o materials, humectants, water, buffering agents, abrasive polishing materials, surfactants, titanium dioxide, flavor system, sweetening agents, coloring agents, and mixtures thereof.
The present compositions comprise essential components, as well as optional components. The essential and optional components of the compositions of the present ~ s invention are described in the following paragraphs.
Fluoride Ion Source The present invention incorporates a soluble fluoride source capable of providing free fluoride ions. Preferred soluble fluoride ion sources include sodium fluoride, stannous fluoride, indium fluoride, and sodium monofluorophosphate.
Sodium zo fluoride is the most preferred soluble fluoride ion source. Norris et al., U.S. Patent 2,946,725, issued July 26, 1960, and Widder et al., U. S. Patent 3,678,154 issued July 18, 1972, disclose such fluoride ion sources as well as others. Both patents are incorporated herein by reference in their entirety.
The present compositions contain a soluble fluoride source capable of providing zs from about 50 ppm to about 3500 ppm, and preferably from about 500 ppm to about 3000 ppm of free fluoride ions.
Pyrophos~hate source The present invention also includes a pyrophosphate source. The pyrophosphate source comprises predominately undissolved pyrophosphate. Undissolved 3o pyrophosphate compositions are defined as compositions containing no more than about 20% of the total pyrophosphate salt dissolved in the composition, preferably less than ~ about 10% of the total pyrophosphate dissolved in the composition.
Tetrasodium pyrophosphate salt is the preferred pyrophosphate salt in these compositions.
It is also preferred that tetrasodium pyrophosphate be the only pyrophosphate or tartar control 3s agent used.
Tetrasodium pyrophosphate may be the anhydrous salt form or the decahydrate form, or any other species stable in solid form in the dentifrice compositions. The anhydrous salt is in its solid particle form, which may be its crystalline and/or amorphous state, with the particle size of the salt preferably being small enough to be s aesthetically acceptable and readily soluble during use. The amount of pyrophosphate salt useful in making these compositions is any tartar control effective amount, and is generally from about 1.5% to about I S%, preferably from about 2% to about 10%, and most preferably from about 3% to about 8%, by weight of the composition. Some or all of the tetrasodium pyrophosphate is undissolved in the product and is present as ~ o tetrasodium pyrophosphate particles. Pyrophosphate ions in different protonated states (e.g., HP207-3) may also exist depending upon the pH of the composition and if part of the tetrasodium pyrophosphate is dissolved.
The pyrophosphate salts are described in more detail in Kirk & Othmer, Encyclopedia of Chemical Technology, Third Edition, Volume 17, Wiley-Interscience ~ s Publishers ( 1982), incorporated herein by reference in its entirety, including all references incorporated into Kirk & Othmer.
Optional anticalculus agents that may be used in combination with the pyrophosphate salt include such known materials as synthetic anionic polymers [including polyacrylates and copolymers of malefic anhydride or acid and methyl vinyl 2o ether (e.g., Gantrez), as described, for example, in U.S. Patent 4,627,977, to Gaffar et al., the disclosure of which is incorporated herein by reference in its entirety; as well as, e.g., polyamino propoane sulfonic acid (AMPS)], zinc citrate trihydrate, polyphosphates (e.g., tripolyphosphate; hexametaphosphate), diphosphonates (e.g., EHDP; AHP), polypeptides (such as polyaspartic and polyglutamic acids), and mixtures thereof.
2s Calcium Peroxide The present invention also includes calcium peroxide. The following amounts represent the amount of peroxide raw material, although the calcium peroxide may contain ingredients other than the peroxide raw material. The present compositions contain from about 0.01 % to about 5%, preferably from about 0.1 % to about 3%, mare 3o preferably from about 0.2% to about 1 %, and most preferably from about 0.3% to about 0.8% of calcium peroxide, by weight of the total composition.
The pH of the present compositions is adjusted to a neat pH range of from about 9.0 to about 10.5. The term "neat pH", as used herein, is defined as the pH of the 3s composition before the composition is diluted or contacted by the mouth.
The neat pH
is adjusted by the use of buffering agents. The neat pH of the present composition is from about 9.0 to about 10.5, preferably from about 9.2 to about 10.2, and more preferably from about 9.5 to about 10.
Water s Water is also contained in the present invention. Water used in the preparation of these compositions should preferably be of low ion content and free of organic impurities. The "total water content" of the composition, as used herein, includes the free water which is added plus the water which is introduced with other materials, such as with sorbitol, silica, color solutions, or surfactant solutions. The total water content of the present invention is from about 9.1 % to about 20%, preferably from about 9.2%
to about 14%, more preferably from about 9.5% to about 13%, and most preferably from about 10% to about 11 %, by weight of the total composition.
Alkali Metal Bicarbonate Salt The present invention may also include an alkali metal bicarbonate salt.
Alkali i s metal bicarbonate salts are soluble in water and unless stabilized, tend to release carbon dioxide in an aqueous system. Sodium bicarbonate, also known as baking soda, is the preferred alkali metal bicarbonate salt. The present compositions may contain from about 0.5% to about 40%, preferably from about 0.5% to about 20%, more preferably from about 0.5% to about 5%, and most preferably from about 0.8% to about 2%
of an 2o alkali metal bicarbonate salt, by weight of the total composition.
Xvlitol The present invention may also include xylitol. Xylitol is a sugar alcohol that is used as a sweetener and humectant. Xylitol may provide a therapeutic effect, such as an antibacterial or anticaries effect. The present compositions may comprise xylitol at a 2s level from about 0.01% to about 25%, preferably from about 3% to about 15%, more preferably from about 5% to about 12%, and most preferably from about 9% to about 11%, by weight of the total composition.
Agueous Carriers In preparing the present compositions, it is desirable to add one or more aqueous 3o carriers to the compositions. Aqueous carriers contain materials that are well known in the art and readily chosen by one skilled in the art based on the physical and aesthetic properties desired for the compositions being prepared. Aqueous carriers typically comprise from about 80% to about 98%, and preferably from about 85% to about 95%, by weight of the total composition.
3s The present invention compositions in the form of toothpastes, typically contain some thickening material or binders to provide a desirable consistency.
Preferred thickening agents are carboxyvinyl polymers, carrageenan, hydroxyethyl cellulose, and water soluble salts of cellulose ethers such as sodium carboxymethylcellulose and sodium carboxymethyl hydroxyethyl cellulose. Natural gums such as gum karaya, xanthan gum, gum arabic, and gum tragacanth can also be used. Colloidal magnesium s aluminum silicate, lithium aluminum magnesium silicate (tradename Laponite), or finely divided silica can be used as part of the thickening agent to further improve texture. Thickening agents can be used in an amount of from about 0.1 % to about 15%, by weight of the total composition.
Another optional component of the compositions desired herein is a humectant.
t o The humectant serves to keep toothpaste compositions from hardening upon exposure to air and certain humectants can also impart desirable sweetness of flavor to toothpaste compositions. Suitable humectants for use in the invention include glycerin, sorbitol, polyethylene glycol, propylene glycol, and other edible polyhydric alcohols.
Polyethylene glycols are one of the preferred humectants. Polyethylene glycols useful t s herein are those which are liquids at room temperature or have a melting point slightly there above. Liquid and low-melting polyethylene glycols are commercially available from Union Carbide under the Carbowax~ tradename. Preferred are those polyethylene glycols having a molecular weight range of from about 200 to about 2000 and corresponding n values of from about 4 to about 40. More preferred are polyethylene 2o glycols having a molecular weight range of from about 400 to about 1600 and most preferred are polyethylene glycols having a molecular weight range of from about 570 to about 630. The humectant generally comprises from about 0% to 70%, and preferably from about 15% to 55%, by weight of the compositions herein.
Buffering agents may be used to adjust the pH of the present compositions.
2s Buffering agents, as used herein, refer to agents that can be used to adjust the pH of the compositions to a neat pH range of from about 9.0 to about 10.5. These agents include alkali metal hydroxides, carbonates, sesquicarbonates, borates, and silicates.
Specific buffering agents include monosodium phosphate, trisodium phosphate, sodium hydroxide, potassium hydroxide, and sodium carbonate. Buffering agents can be used 3o at a level of from about 0.5% to about 10%, by weight of the present compositions.
An abrasive polishing material may also be included in the toothpaste compositions. The abrasive polishing material contemplated for use in the compositions of the present invention can be any material which does not excessively abrade dentin. These include, for example, silicas including gels and precipitates, 3s calcium carbonate, dicalcium orthophosphate dihydrate, calcium pyrophosphate, tricalcium phosphate, calcium polymetaphosphate, insoluble sodium ,7 polymetaphosphate, hydrated alumina, and resinous abrasive materials such as particulate condensation products of urea and formaldehyde, and others such as disclosed by.Cooley et al in U.S. Pat. No. 3,070,510, issued Dec. 25, 1962, incorporated herein by reference. Mixtures of abrasives may also be used.
s Silica dental abrasives of various types are preferred because of their unique benefits of exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentine. The silica abrasive polishing materials herein, as well as other abrasives, generally have an average particle size ranging between about 0.1 to about 30 microns, and preferably from about 5 to about 15 microns. The abrasive can t o be precipitated silica or silica gels such as the silica xerogels described in Pader et al., U.S. Patent 3,538,230, issued Mar. 2, 1970, and DiGiulio, U.S. Patent 3,862,307, issued Jan. 21, ,1975, both incorporated herein by reference. Preferred are the silica xerogels marketed under the trade name "Syloid" by the W.R. Grace & Company, Davison Chemical Division. Also preferred are the precipitated silica materials such as those ~ s marketed by the J. M. Huber Corporation under the trade name, "Zeodent", particularly the silica carrying the designation "Zeodent 119". The types of silica dental abrasives useful in the toothpastes of the present invention are described in more detail in Wason, U.S. Patent 4,340,583, issued July 29, l982, incorporated herein by reference. The abrasive in the toothpaste compositions described herein is generally present at a level 20 of from about 6% to about 70%, by weight of the composition.
Preferably, toothpastes contain from about 10% to about 50% of abrasive, by weight of the composition.
The present composition may also comprise surfactants, also commonly referred to as sudsing agents. Suitable surfactants are those which are reasonably stable and foam throughout a wide pH range. The surfactant may be anionic, nonionic, 2s amphoteric, zwitterionic, cationic, or mixtures thereof.
Anionic surfactants useful herein include the water-soluble salts of alkyl sulfates having from 8 to 20 carbon atoms in the alkyl radical (e.g., sodium alkyl sulfate) and the water-soluble salts of sulfonated monoglycerides of fatty acids having from 8 to 20 carbon atoms. Sodium lauryl sulfate and sodium coconut monoglyceride sulfonates are examples of anionic surfactants of 3o this type. Other suitable anionic surfactants are sarcosinates, such as sodium lauroyl sarcosinate, taurates, sodium lauryl sulfoacetate, sodium lauroyl isethionate, sodium . Iaureth carboxylate, and sodium dodecyl benzenesulfonate.
Mixtures of anionic surfactants can also be employed. Many suitable anionic surfactants are disclosed by Agricola et al., U.S. Patent 3,959,4S8, issued May 25, 1976, incorporated herein in its 3s entirety by reference. Nonionic surfactants which can be used in the compositions of the present invention can be broadly defined as compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound which may be aliphatic or alkyl-aromatic in nature.
Examples of suitable nonionic surfactants include poloxamers (sold under trade name Piuronic), polyoxyethylene sorbitan esters (sold under trade name Tweens), fatty alcohol s ethoxylates, polyethylene oxide condensates of alkyl phenols, products derived from the condensation of ethylene oxide with the reaction product of propylene oxide and ethylene diamine, ethylene oxide condensates of aliphatic alcohols, long chain tertiary amine oxides, long chain tertiary phosphine oxides, long chain dialkyl sulfoxides, and mixtures of such materials. The amphoteric surfactants useful in the present invention io can be broadly described as derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be a straight chain or branched and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic water-solubilizing group, e.g., carboxylate, sulfonate, sulfate, phosphate, or phosphonate. Other suitable amphoteric surfactants are betaines, specifically ~ s cocamidopropyl betaine. Mixtures of amphoteric surfactants can also be employed.
Many of these suitable nonionic and amphoteric surfactants are disclosed by Gieske et al., U.S. Patent 4,051,234, issued September 27, 1977, incorporated herein by reference in its entirety. The present compositions may comprise one or more surfactants each at a level of from about 0.25% to about 10%, preferably from about 0.5% to about 8%, and Zo most preferably from about 1 % to about 6%, by weight of the composition.
Titanium dioxide may also be added to the present composition. Titanium dioxide is a white powder which adds opacity to the compositions. Titanium dioxide may comprise from about 0.25% to about 5%, by weight of the compositions.
Coloring agents may also be added to the present composition. The coloring 2s agent may be in the form of an aqueous solution, preferably a 1 % color solution. Color solutions may comprise from about 0.01 % to about S%, by weight of the composition.
A flavor system can also be added to the compositions. Suitable flavoring components include.oil of wintergreen, oil of peppermint, oil of spearmint, clove bud oil, menthol, anethole, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, 3o eugenol, parsley oil, oxanone, alpha-irisone, marjoram, lemon, orange, propenyl guaethol, cinnamon, vanillin, ethyl vanillin, heliotropine, 4-cis-heptenal, diacetyl, methyl-para-tert-butyl phenyl acetate, and mixtures thereof. Coolants may also be part of the flavor system. Preferred coolants in the present compositions are the paramenthan carboxyamide agents such as N-ethyl-p-menthan-3-carboxamide (known 3s commercially as "WS-3") and mixtures thereof. A flavor system is generally used in the compositions at levels of from about 0.001 % to about 5%, by weight of the composition.
Sweetening agents can be added to the compositions. These include sodium saccharin, dextrose, sucrose, lactose, maltose, levulose, aspartame, sodium cyclamate, s D-tryptophan, dihydrochalcones, acesulfame, and mixtures thereof. Sweetening agents ' are generally used in toothpastes at levels of from about 0.005% to about 5%, by weight of the composition.
The present invention may also include other agents. Included among such agents are water insoluble non-cationic agents such as triclosan and other agents of the ~o type disclosed in Parran, Jr. et al., U.S. Patent 5,015,4b6, issued May 14, 1991, incorporated by reference herein in its entirety.
The composition may be a multilayer toothpaste composition. This composition may comprise two or more separate layers which are in contact with each other.
Preferably, the separate layers are pastes and gels that when extruded from the tube, ~ s appear as combination paste/gel stripes. One of the layers in this paste/gel stripe combination must comprise all of the essential components, while the other layers may contain less than all of the essential components and may be any dentifrice formulation.
Preferably, the gel layers do not comprise the essential component of calcium peroxide.
Alternatively, the dentifrice compositions may be physically separated in a 2o dentifrice dispenser. The dispenser may be a tube, pump, or any other container suitable for dispensing toothpaste. Dual compartment packages suitable for this purpose are described in U.S. Patent 4,528,180, issued July 9, 198S; U.S. Patent 4,687,663, issued August 18, 1987; and 4,849,213, issued July 18, 1989, all to Shaeffer, a11 incorporated herein in their entirety. The dispenser will deliver approximately equal amounts of each 2s dentifrice composition through an opening. The compositions may intermix once dispensed. Alternatively, the oral formulation may be delivered from a kit containing two separate dispensers which are used to deliver two dentifrice compositions that are both used simultaneously.
Method of Manufacturing 3o Toothpaste compositions comprising a soluble fluoride source capable of providing from about 50 ppm to about 3500 ppm of firee fluoride ions, an amount of at > least about ~ 1.5% tetrasodium pyrophosphate, from about 0.01 % to about 5%
of calcium peroxide; and from about 80% to about 98% of one or more aqueous carriers, are made by a process comprising the steps of (a) preparing a mixture of a soluble fluoride ion 3s source and one or more aqueous carrier materials; (b) adding tetrasodium pyrophosphate and calcium peroxide, a11 at once or in portions, under conditions wherein less than about 20% of the total pyrophosphate and calcium peroxide are dissolved in the dentifrice mixture; and wherein further any remaining aqueous carrier materials not added to the mixture during step (a) are added in whole or in part in step (b) or thereafter, either by themselves or with any remaining amount of the tetrasodium s pyrophosphate or calcium peroxide, under conditions such that less than about 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture; and (c) heating the mixture to a temperature range of from about 3 8° C ( 100° F) to about 71 ° C
( 160° F) and preferably to a temperature range of from about 52° C ( 125 ° F) to about 57 ° C (135° F). The amount of pyrophosphate dissolved in the mixture for the methods ~ o and compositions of the present invention is preferably less than about 10% by weight of the total pyrophosphate present in the compositions and the amount of calcium peroxide dissolved in the mixtures is preferably less than about 10% by weight of the total amount of calcium peroxide present in the compositions.
The dentifrice mixtures will have a viscosity of from about 10 to about 60 t s Brookfield units at 23 ° C in bulk or packed product from about 10 minutes to about two hours after being made or packed. The viscosity then builds to a viscosity of from about 30 to about 125 Brookfield units at 23° C in bulk or packed product after about one month or more after being made or packed. Preferably, the viscosity is from about 20 to about 50 Brookfield units at 23° C in bulk or packed product from about 10 minutes to 2o about two hours after being made or packed and the viscosity builds to a viscosity of from about 60 to about 80 Brookfield units at 23° C in bulk or packed product after about one month or more after being made or packed. The viscosity is measured with a Brookfield Synchrolectric Viscometer Model RVT/2 using a T-E spindle at 2.5 revolutions per minute.
2s Preferably, one or more of the following process conditions are controlled as follows to limit the solubility of the tetrasodium pyrophosphate and calcium peroxide in the dentifrice mixture: ( 1 ) the neat pH of the process mixture is above about pH 8, preferably above about pH 9, during and after the tetrasodium pyrophosphate and calcium peroxide additions are made to the mixture; and (2) the tetrasodium 3o pyrophosphate salt and peroxide are two of the last components to be added to the mixture, preferably after all or much of the other sodium-containing salts present in the composition have been added to the mixture. By these methods, the dissolved tetrasodium pyrophosphate salt is less likely to recrystalize in the form of glass-like crystal particles of tetrasodium pyrophosphate decahydrate and the peroxide is less 3s likely to breakdown and react with the fluoride to form calcium fluoride.
During step (c), the heating step, the mixture is heated to a temperature range of from about 38° C (100° F) to about 71° C (l60° F) and preferably to a temperature range of from about 52° C (125° F) to about 57° C (l35 ° F). One or more heating variables may be controlled during this step. The heating variables include:
the rate of s heating the mixture to the temperature range, the amount of time that the composition is kept at this temperature range, and the rate of cooling the mixture from the temperature range. Additionally, another heating variable is homogenization.
Homogenization of the mixture may occur while the mixture is within the temperature range.
After step (c), the toothpaste is fed into a suitable dispensing tube or container.
i o After filling the tube with toothpaste, the open end of the tube is sealed. If the toothpaste is to be a multilayer composition, the desired toothpaste layers are fed in parallel streams to form a multilayered appearance and then the open end of the tube is sealed. The dentifrice layers will be extruded in the desired multilayer configuration when dispensed from the tube.
is Method of Treatment The present invention compositions additionally relate to a method for reducing the incidence of calculus on dental enamel. The method of treatment herein comprises contacting the dental enamel surfaces in the mouth with the oral compositions according to the present invention.
2o The following examples further describe and demonstrate embodiments within the scope of the present invention. These examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention as many variations thereof are possible without departing from the spirit and scope.
2s EXAMPLE I
Instredient Wei hg t%
Glycerin 28.885 Polyethylene Glycol 12 1.000 Xanthan Gum 0.300 3o Carboxymethylcellulose 0.200 Water 5.000 Sodium Saccharin 0.450 Sodium Fluoride 0.243 Poloxamer 407 2.000 3s Sodium Alkyl Sulfate (a) 6.000 Flavor 1.150 Sodium Carbonate 2.800 Titanium Dioxide 1.000 Silica 20.000 Sodium Bicarbonate 10.000 s Propylene Glycol 10.562 Tetrasodium Pyrophosphate 8.4l0 Calcium Peroxide 2.000 Example I is prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthan gum, in ~ o the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol. Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. Add the poloxamer.
The flavor and sodium alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Add the sodium bicarbonate. Disperse the tetrasodium t s pyrophosphate in the remaining glycerin and add to the mixture. Finally, add the calcium peroxide. Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This temperature should be maintained for about 30-60 minutes. Finally, the mixture may be cooled and deaerated.
zo EXAMPLE II
In redient Wei hg t%
Glycerin 28.990 Polyethylene Glycol 12 3.000 Xanthan Gum 0.400 2s Carboxymethylcellulose 0.250 Water 5.000 Sodium Saccharin 0.450 Sodium Fluoride 0.243 Xylitol 10.000 3o Poloxamer 407 3.000 Sodium Alkyl Sulfate Via) 6.000 Flavor 1.150 Sodium Carbonate 2.8d0 Titanium Dioxide I .000 3s Silica 20.000 Sodium Bicarbonate 1.000 Propylene Glycol 11.57l Tetrasodium Pyrophosphate 5.046 Calcium Peroxide 0.l00 s EXAMPLE III
,IJn gredient Weight Glycerin 27.050 Polyethylene Glycol 12 2.000 Xanthan Gum 0.300 Carboxymethylcellulose 0.200 Water 5.000 Sodium Saccharin 0.450 Sodium Fluoride 0.243 Xylitol 10.000 t s Poloxamer 407 2.000 Sodium Alkyl Sulfate (a) 6.000 Flavor 1.100 Sodium Carbonate 2.600 Titanium Dioxide 1.000 2o Silica 20.000 Sodium Bicarbonate 1.500 Propylene Glycol l5.011 Tetrasodium Pyrophosphate 5.046 Calcium Peroxide 0.500 2s Examples II and III are prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthari gum, in the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol.
Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. Add the xylitol 3o and poloxamer. The flavor and sodium alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Add the sodium bicarbonate.
Disperse the tetrasodium pyrophosphate in the remaining glycerin and add to the mixture. Finally, add the calcium peroxide. Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This 3s temperature should be maintained for about 30-60 minutes. Finally, the mixture may be cooled and deaerated.
EXAMPLE IV
In reg-diem Wei hg t Glycerin 28.611 s Polyethylene Glycol 6 1.000 Xanthan Gum 0.350 Carboxymethylcellulose 0.250 Water 6.400 Sodium Saccharin 0.300 Sodium Fluoride 0.243 Sodium Alkyl Sulfate Via) 6.000 Flavor 0.900 Sodium Carbonate 2.800 Titanium Dioxide 0.500 ~ s Silica 10.000 Sodium Bicarbonate 30.000 Propylene Glycol 7.S00 Tetrasodium Pyrophosphate 5.046 Calcium Peroxide 0.100 2o Example IV is prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthan gum, in the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol. Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. The flavor and sodium 2s alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Add the sodium bicarbonate. Disperse the, tetrasodium pyrophosphate in the remaining glycerin and add to the mixture. Finally, add the calcium peroxide.
Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This temperature should be maintained for about 30-60 3o minutes. Finally, the mixture may be cooled and deaerated.
EXAMPLE V
In red~ient Wei hg t Glycerin 24.461 3s Polyethylene Glycol 12 1.000 Xanthan Gum 0.500 Carboxymethylcellulose 0.3 SO
Water 11.500 Sodium Saccharin 0.4S0 s Sodium Fluoride 0.243 Xylitol 20.000 Sodium Alkyl Sulfate Via) 6.000 Flavor 1.1S0 Sodium Carbonate 2.800 i o Titanium Dioxide 1.000 Silica 1 S.000 Propylene Glycol 10.000 Tetrasodium Pyrophosphate S.046 Calcium Peroxide 0.S00 ~ s _______________________ Via) 27.9% solution of sodium alkyl sulfate in water Example V is prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthan gum, in 2o the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol. Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. Add the xylitol. The flavor and sodium alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Disperse the tetrasodium pyrophosphate in the 2s remaining glycerin and add to the mixture. Finally, add the calcium peroxide. Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This temperature should be maintained for about 30-60 minutes. Finally, the mixture may be cooled and deaerated.
The pyrophosphate salts are described in more detail in Kirk & Othmer, Encyclopedia of Chemical Technology, Third Edition, Volume 17, Wiley-Interscience ~ s Publishers ( 1982), incorporated herein by reference in its entirety, including all references incorporated into Kirk & Othmer.
Optional anticalculus agents that may be used in combination with the pyrophosphate salt include such known materials as synthetic anionic polymers [including polyacrylates and copolymers of malefic anhydride or acid and methyl vinyl 2o ether (e.g., Gantrez), as described, for example, in U.S. Patent 4,627,977, to Gaffar et al., the disclosure of which is incorporated herein by reference in its entirety; as well as, e.g., polyamino propoane sulfonic acid (AMPS)], zinc citrate trihydrate, polyphosphates (e.g., tripolyphosphate; hexametaphosphate), diphosphonates (e.g., EHDP; AHP), polypeptides (such as polyaspartic and polyglutamic acids), and mixtures thereof.
2s Calcium Peroxide The present invention also includes calcium peroxide. The following amounts represent the amount of peroxide raw material, although the calcium peroxide may contain ingredients other than the peroxide raw material. The present compositions contain from about 0.01 % to about 5%, preferably from about 0.1 % to about 3%, mare 3o preferably from about 0.2% to about 1 %, and most preferably from about 0.3% to about 0.8% of calcium peroxide, by weight of the total composition.
The pH of the present compositions is adjusted to a neat pH range of from about 9.0 to about 10.5. The term "neat pH", as used herein, is defined as the pH of the 3s composition before the composition is diluted or contacted by the mouth.
The neat pH
is adjusted by the use of buffering agents. The neat pH of the present composition is from about 9.0 to about 10.5, preferably from about 9.2 to about 10.2, and more preferably from about 9.5 to about 10.
Water s Water is also contained in the present invention. Water used in the preparation of these compositions should preferably be of low ion content and free of organic impurities. The "total water content" of the composition, as used herein, includes the free water which is added plus the water which is introduced with other materials, such as with sorbitol, silica, color solutions, or surfactant solutions. The total water content of the present invention is from about 9.1 % to about 20%, preferably from about 9.2%
to about 14%, more preferably from about 9.5% to about 13%, and most preferably from about 10% to about 11 %, by weight of the total composition.
Alkali Metal Bicarbonate Salt The present invention may also include an alkali metal bicarbonate salt.
Alkali i s metal bicarbonate salts are soluble in water and unless stabilized, tend to release carbon dioxide in an aqueous system. Sodium bicarbonate, also known as baking soda, is the preferred alkali metal bicarbonate salt. The present compositions may contain from about 0.5% to about 40%, preferably from about 0.5% to about 20%, more preferably from about 0.5% to about 5%, and most preferably from about 0.8% to about 2%
of an 2o alkali metal bicarbonate salt, by weight of the total composition.
Xvlitol The present invention may also include xylitol. Xylitol is a sugar alcohol that is used as a sweetener and humectant. Xylitol may provide a therapeutic effect, such as an antibacterial or anticaries effect. The present compositions may comprise xylitol at a 2s level from about 0.01% to about 25%, preferably from about 3% to about 15%, more preferably from about 5% to about 12%, and most preferably from about 9% to about 11%, by weight of the total composition.
Agueous Carriers In preparing the present compositions, it is desirable to add one or more aqueous 3o carriers to the compositions. Aqueous carriers contain materials that are well known in the art and readily chosen by one skilled in the art based on the physical and aesthetic properties desired for the compositions being prepared. Aqueous carriers typically comprise from about 80% to about 98%, and preferably from about 85% to about 95%, by weight of the total composition.
3s The present invention compositions in the form of toothpastes, typically contain some thickening material or binders to provide a desirable consistency.
Preferred thickening agents are carboxyvinyl polymers, carrageenan, hydroxyethyl cellulose, and water soluble salts of cellulose ethers such as sodium carboxymethylcellulose and sodium carboxymethyl hydroxyethyl cellulose. Natural gums such as gum karaya, xanthan gum, gum arabic, and gum tragacanth can also be used. Colloidal magnesium s aluminum silicate, lithium aluminum magnesium silicate (tradename Laponite), or finely divided silica can be used as part of the thickening agent to further improve texture. Thickening agents can be used in an amount of from about 0.1 % to about 15%, by weight of the total composition.
Another optional component of the compositions desired herein is a humectant.
t o The humectant serves to keep toothpaste compositions from hardening upon exposure to air and certain humectants can also impart desirable sweetness of flavor to toothpaste compositions. Suitable humectants for use in the invention include glycerin, sorbitol, polyethylene glycol, propylene glycol, and other edible polyhydric alcohols.
Polyethylene glycols are one of the preferred humectants. Polyethylene glycols useful t s herein are those which are liquids at room temperature or have a melting point slightly there above. Liquid and low-melting polyethylene glycols are commercially available from Union Carbide under the Carbowax~ tradename. Preferred are those polyethylene glycols having a molecular weight range of from about 200 to about 2000 and corresponding n values of from about 4 to about 40. More preferred are polyethylene 2o glycols having a molecular weight range of from about 400 to about 1600 and most preferred are polyethylene glycols having a molecular weight range of from about 570 to about 630. The humectant generally comprises from about 0% to 70%, and preferably from about 15% to 55%, by weight of the compositions herein.
Buffering agents may be used to adjust the pH of the present compositions.
2s Buffering agents, as used herein, refer to agents that can be used to adjust the pH of the compositions to a neat pH range of from about 9.0 to about 10.5. These agents include alkali metal hydroxides, carbonates, sesquicarbonates, borates, and silicates.
Specific buffering agents include monosodium phosphate, trisodium phosphate, sodium hydroxide, potassium hydroxide, and sodium carbonate. Buffering agents can be used 3o at a level of from about 0.5% to about 10%, by weight of the present compositions.
An abrasive polishing material may also be included in the toothpaste compositions. The abrasive polishing material contemplated for use in the compositions of the present invention can be any material which does not excessively abrade dentin. These include, for example, silicas including gels and precipitates, 3s calcium carbonate, dicalcium orthophosphate dihydrate, calcium pyrophosphate, tricalcium phosphate, calcium polymetaphosphate, insoluble sodium ,7 polymetaphosphate, hydrated alumina, and resinous abrasive materials such as particulate condensation products of urea and formaldehyde, and others such as disclosed by.Cooley et al in U.S. Pat. No. 3,070,510, issued Dec. 25, 1962, incorporated herein by reference. Mixtures of abrasives may also be used.
s Silica dental abrasives of various types are preferred because of their unique benefits of exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentine. The silica abrasive polishing materials herein, as well as other abrasives, generally have an average particle size ranging between about 0.1 to about 30 microns, and preferably from about 5 to about 15 microns. The abrasive can t o be precipitated silica or silica gels such as the silica xerogels described in Pader et al., U.S. Patent 3,538,230, issued Mar. 2, 1970, and DiGiulio, U.S. Patent 3,862,307, issued Jan. 21, ,1975, both incorporated herein by reference. Preferred are the silica xerogels marketed under the trade name "Syloid" by the W.R. Grace & Company, Davison Chemical Division. Also preferred are the precipitated silica materials such as those ~ s marketed by the J. M. Huber Corporation under the trade name, "Zeodent", particularly the silica carrying the designation "Zeodent 119". The types of silica dental abrasives useful in the toothpastes of the present invention are described in more detail in Wason, U.S. Patent 4,340,583, issued July 29, l982, incorporated herein by reference. The abrasive in the toothpaste compositions described herein is generally present at a level 20 of from about 6% to about 70%, by weight of the composition.
Preferably, toothpastes contain from about 10% to about 50% of abrasive, by weight of the composition.
The present composition may also comprise surfactants, also commonly referred to as sudsing agents. Suitable surfactants are those which are reasonably stable and foam throughout a wide pH range. The surfactant may be anionic, nonionic, 2s amphoteric, zwitterionic, cationic, or mixtures thereof.
Anionic surfactants useful herein include the water-soluble salts of alkyl sulfates having from 8 to 20 carbon atoms in the alkyl radical (e.g., sodium alkyl sulfate) and the water-soluble salts of sulfonated monoglycerides of fatty acids having from 8 to 20 carbon atoms. Sodium lauryl sulfate and sodium coconut monoglyceride sulfonates are examples of anionic surfactants of 3o this type. Other suitable anionic surfactants are sarcosinates, such as sodium lauroyl sarcosinate, taurates, sodium lauryl sulfoacetate, sodium lauroyl isethionate, sodium . Iaureth carboxylate, and sodium dodecyl benzenesulfonate.
Mixtures of anionic surfactants can also be employed. Many suitable anionic surfactants are disclosed by Agricola et al., U.S. Patent 3,959,4S8, issued May 25, 1976, incorporated herein in its 3s entirety by reference. Nonionic surfactants which can be used in the compositions of the present invention can be broadly defined as compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound which may be aliphatic or alkyl-aromatic in nature.
Examples of suitable nonionic surfactants include poloxamers (sold under trade name Piuronic), polyoxyethylene sorbitan esters (sold under trade name Tweens), fatty alcohol s ethoxylates, polyethylene oxide condensates of alkyl phenols, products derived from the condensation of ethylene oxide with the reaction product of propylene oxide and ethylene diamine, ethylene oxide condensates of aliphatic alcohols, long chain tertiary amine oxides, long chain tertiary phosphine oxides, long chain dialkyl sulfoxides, and mixtures of such materials. The amphoteric surfactants useful in the present invention io can be broadly described as derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be a straight chain or branched and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic water-solubilizing group, e.g., carboxylate, sulfonate, sulfate, phosphate, or phosphonate. Other suitable amphoteric surfactants are betaines, specifically ~ s cocamidopropyl betaine. Mixtures of amphoteric surfactants can also be employed.
Many of these suitable nonionic and amphoteric surfactants are disclosed by Gieske et al., U.S. Patent 4,051,234, issued September 27, 1977, incorporated herein by reference in its entirety. The present compositions may comprise one or more surfactants each at a level of from about 0.25% to about 10%, preferably from about 0.5% to about 8%, and Zo most preferably from about 1 % to about 6%, by weight of the composition.
Titanium dioxide may also be added to the present composition. Titanium dioxide is a white powder which adds opacity to the compositions. Titanium dioxide may comprise from about 0.25% to about 5%, by weight of the compositions.
Coloring agents may also be added to the present composition. The coloring 2s agent may be in the form of an aqueous solution, preferably a 1 % color solution. Color solutions may comprise from about 0.01 % to about S%, by weight of the composition.
A flavor system can also be added to the compositions. Suitable flavoring components include.oil of wintergreen, oil of peppermint, oil of spearmint, clove bud oil, menthol, anethole, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, 3o eugenol, parsley oil, oxanone, alpha-irisone, marjoram, lemon, orange, propenyl guaethol, cinnamon, vanillin, ethyl vanillin, heliotropine, 4-cis-heptenal, diacetyl, methyl-para-tert-butyl phenyl acetate, and mixtures thereof. Coolants may also be part of the flavor system. Preferred coolants in the present compositions are the paramenthan carboxyamide agents such as N-ethyl-p-menthan-3-carboxamide (known 3s commercially as "WS-3") and mixtures thereof. A flavor system is generally used in the compositions at levels of from about 0.001 % to about 5%, by weight of the composition.
Sweetening agents can be added to the compositions. These include sodium saccharin, dextrose, sucrose, lactose, maltose, levulose, aspartame, sodium cyclamate, s D-tryptophan, dihydrochalcones, acesulfame, and mixtures thereof. Sweetening agents ' are generally used in toothpastes at levels of from about 0.005% to about 5%, by weight of the composition.
The present invention may also include other agents. Included among such agents are water insoluble non-cationic agents such as triclosan and other agents of the ~o type disclosed in Parran, Jr. et al., U.S. Patent 5,015,4b6, issued May 14, 1991, incorporated by reference herein in its entirety.
The composition may be a multilayer toothpaste composition. This composition may comprise two or more separate layers which are in contact with each other.
Preferably, the separate layers are pastes and gels that when extruded from the tube, ~ s appear as combination paste/gel stripes. One of the layers in this paste/gel stripe combination must comprise all of the essential components, while the other layers may contain less than all of the essential components and may be any dentifrice formulation.
Preferably, the gel layers do not comprise the essential component of calcium peroxide.
Alternatively, the dentifrice compositions may be physically separated in a 2o dentifrice dispenser. The dispenser may be a tube, pump, or any other container suitable for dispensing toothpaste. Dual compartment packages suitable for this purpose are described in U.S. Patent 4,528,180, issued July 9, 198S; U.S. Patent 4,687,663, issued August 18, 1987; and 4,849,213, issued July 18, 1989, all to Shaeffer, a11 incorporated herein in their entirety. The dispenser will deliver approximately equal amounts of each 2s dentifrice composition through an opening. The compositions may intermix once dispensed. Alternatively, the oral formulation may be delivered from a kit containing two separate dispensers which are used to deliver two dentifrice compositions that are both used simultaneously.
Method of Manufacturing 3o Toothpaste compositions comprising a soluble fluoride source capable of providing from about 50 ppm to about 3500 ppm of firee fluoride ions, an amount of at > least about ~ 1.5% tetrasodium pyrophosphate, from about 0.01 % to about 5%
of calcium peroxide; and from about 80% to about 98% of one or more aqueous carriers, are made by a process comprising the steps of (a) preparing a mixture of a soluble fluoride ion 3s source and one or more aqueous carrier materials; (b) adding tetrasodium pyrophosphate and calcium peroxide, a11 at once or in portions, under conditions wherein less than about 20% of the total pyrophosphate and calcium peroxide are dissolved in the dentifrice mixture; and wherein further any remaining aqueous carrier materials not added to the mixture during step (a) are added in whole or in part in step (b) or thereafter, either by themselves or with any remaining amount of the tetrasodium s pyrophosphate or calcium peroxide, under conditions such that less than about 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture; and (c) heating the mixture to a temperature range of from about 3 8° C ( 100° F) to about 71 ° C
( 160° F) and preferably to a temperature range of from about 52° C ( 125 ° F) to about 57 ° C (135° F). The amount of pyrophosphate dissolved in the mixture for the methods ~ o and compositions of the present invention is preferably less than about 10% by weight of the total pyrophosphate present in the compositions and the amount of calcium peroxide dissolved in the mixtures is preferably less than about 10% by weight of the total amount of calcium peroxide present in the compositions.
The dentifrice mixtures will have a viscosity of from about 10 to about 60 t s Brookfield units at 23 ° C in bulk or packed product from about 10 minutes to about two hours after being made or packed. The viscosity then builds to a viscosity of from about 30 to about 125 Brookfield units at 23° C in bulk or packed product after about one month or more after being made or packed. Preferably, the viscosity is from about 20 to about 50 Brookfield units at 23° C in bulk or packed product from about 10 minutes to 2o about two hours after being made or packed and the viscosity builds to a viscosity of from about 60 to about 80 Brookfield units at 23° C in bulk or packed product after about one month or more after being made or packed. The viscosity is measured with a Brookfield Synchrolectric Viscometer Model RVT/2 using a T-E spindle at 2.5 revolutions per minute.
2s Preferably, one or more of the following process conditions are controlled as follows to limit the solubility of the tetrasodium pyrophosphate and calcium peroxide in the dentifrice mixture: ( 1 ) the neat pH of the process mixture is above about pH 8, preferably above about pH 9, during and after the tetrasodium pyrophosphate and calcium peroxide additions are made to the mixture; and (2) the tetrasodium 3o pyrophosphate salt and peroxide are two of the last components to be added to the mixture, preferably after all or much of the other sodium-containing salts present in the composition have been added to the mixture. By these methods, the dissolved tetrasodium pyrophosphate salt is less likely to recrystalize in the form of glass-like crystal particles of tetrasodium pyrophosphate decahydrate and the peroxide is less 3s likely to breakdown and react with the fluoride to form calcium fluoride.
During step (c), the heating step, the mixture is heated to a temperature range of from about 38° C (100° F) to about 71° C (l60° F) and preferably to a temperature range of from about 52° C (125° F) to about 57° C (l35 ° F). One or more heating variables may be controlled during this step. The heating variables include:
the rate of s heating the mixture to the temperature range, the amount of time that the composition is kept at this temperature range, and the rate of cooling the mixture from the temperature range. Additionally, another heating variable is homogenization.
Homogenization of the mixture may occur while the mixture is within the temperature range.
After step (c), the toothpaste is fed into a suitable dispensing tube or container.
i o After filling the tube with toothpaste, the open end of the tube is sealed. If the toothpaste is to be a multilayer composition, the desired toothpaste layers are fed in parallel streams to form a multilayered appearance and then the open end of the tube is sealed. The dentifrice layers will be extruded in the desired multilayer configuration when dispensed from the tube.
is Method of Treatment The present invention compositions additionally relate to a method for reducing the incidence of calculus on dental enamel. The method of treatment herein comprises contacting the dental enamel surfaces in the mouth with the oral compositions according to the present invention.
2o The following examples further describe and demonstrate embodiments within the scope of the present invention. These examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention as many variations thereof are possible without departing from the spirit and scope.
2s EXAMPLE I
Instredient Wei hg t%
Glycerin 28.885 Polyethylene Glycol 12 1.000 Xanthan Gum 0.300 3o Carboxymethylcellulose 0.200 Water 5.000 Sodium Saccharin 0.450 Sodium Fluoride 0.243 Poloxamer 407 2.000 3s Sodium Alkyl Sulfate (a) 6.000 Flavor 1.150 Sodium Carbonate 2.800 Titanium Dioxide 1.000 Silica 20.000 Sodium Bicarbonate 10.000 s Propylene Glycol 10.562 Tetrasodium Pyrophosphate 8.4l0 Calcium Peroxide 2.000 Example I is prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthan gum, in ~ o the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol. Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. Add the poloxamer.
The flavor and sodium alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Add the sodium bicarbonate. Disperse the tetrasodium t s pyrophosphate in the remaining glycerin and add to the mixture. Finally, add the calcium peroxide. Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This temperature should be maintained for about 30-60 minutes. Finally, the mixture may be cooled and deaerated.
zo EXAMPLE II
In redient Wei hg t%
Glycerin 28.990 Polyethylene Glycol 12 3.000 Xanthan Gum 0.400 2s Carboxymethylcellulose 0.250 Water 5.000 Sodium Saccharin 0.450 Sodium Fluoride 0.243 Xylitol 10.000 3o Poloxamer 407 3.000 Sodium Alkyl Sulfate Via) 6.000 Flavor 1.150 Sodium Carbonate 2.8d0 Titanium Dioxide I .000 3s Silica 20.000 Sodium Bicarbonate 1.000 Propylene Glycol 11.57l Tetrasodium Pyrophosphate 5.046 Calcium Peroxide 0.l00 s EXAMPLE III
,IJn gredient Weight Glycerin 27.050 Polyethylene Glycol 12 2.000 Xanthan Gum 0.300 Carboxymethylcellulose 0.200 Water 5.000 Sodium Saccharin 0.450 Sodium Fluoride 0.243 Xylitol 10.000 t s Poloxamer 407 2.000 Sodium Alkyl Sulfate (a) 6.000 Flavor 1.100 Sodium Carbonate 2.600 Titanium Dioxide 1.000 2o Silica 20.000 Sodium Bicarbonate 1.500 Propylene Glycol l5.011 Tetrasodium Pyrophosphate 5.046 Calcium Peroxide 0.500 2s Examples II and III are prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthari gum, in the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol.
Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. Add the xylitol 3o and poloxamer. The flavor and sodium alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Add the sodium bicarbonate.
Disperse the tetrasodium pyrophosphate in the remaining glycerin and add to the mixture. Finally, add the calcium peroxide. Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This 3s temperature should be maintained for about 30-60 minutes. Finally, the mixture may be cooled and deaerated.
EXAMPLE IV
In reg-diem Wei hg t Glycerin 28.611 s Polyethylene Glycol 6 1.000 Xanthan Gum 0.350 Carboxymethylcellulose 0.250 Water 6.400 Sodium Saccharin 0.300 Sodium Fluoride 0.243 Sodium Alkyl Sulfate Via) 6.000 Flavor 0.900 Sodium Carbonate 2.800 Titanium Dioxide 0.500 ~ s Silica 10.000 Sodium Bicarbonate 30.000 Propylene Glycol 7.S00 Tetrasodium Pyrophosphate 5.046 Calcium Peroxide 0.100 2o Example IV is prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthan gum, in the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol. Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. The flavor and sodium 2s alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Add the sodium bicarbonate. Disperse the, tetrasodium pyrophosphate in the remaining glycerin and add to the mixture. Finally, add the calcium peroxide.
Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This temperature should be maintained for about 30-60 3o minutes. Finally, the mixture may be cooled and deaerated.
EXAMPLE V
In red~ient Wei hg t Glycerin 24.461 3s Polyethylene Glycol 12 1.000 Xanthan Gum 0.500 Carboxymethylcellulose 0.3 SO
Water 11.500 Sodium Saccharin 0.4S0 s Sodium Fluoride 0.243 Xylitol 20.000 Sodium Alkyl Sulfate Via) 6.000 Flavor 1.1S0 Sodium Carbonate 2.800 i o Titanium Dioxide 1.000 Silica 1 S.000 Propylene Glycol 10.000 Tetrasodium Pyrophosphate S.046 Calcium Peroxide 0.S00 ~ s _______________________ Via) 27.9% solution of sodium alkyl sulfate in water Example V is prepared as follows: Add approximately half of the glycerin to a mixing vessel. Disperse the thickening agents, carboxymethyl cellulose and xanthan gum, in 2o the propylene glycol. Add this mixture of dispersed thickening agents in propylene glycol to the mixing vessel and add the polyethylene glycol. Dissolve the sodium fluoride and sodium saccharin in water and add to the mixture. Add the xylitol. The flavor and sodium alkyl sulfate are then added. Next, add the sodium carbonate, titanium dioxide, and the silica. Disperse the tetrasodium pyrophosphate in the 2s remaining glycerin and add to the mixture. Finally, add the calcium peroxide. Stir the mixture until homogeneous and then heat the mixture to a temperature range of from about 110° F to about 160° F. This temperature should be maintained for about 30-60 minutes. Finally, the mixture may be cooled and deaerated.
Claims (10)
1. An oral composition comprising:
a. a soluble fluoride source capable of providing from 50 ppm to 3500 ppm of free fluoride ions;
b. an amount of at least 1.5% tetrasodium pyrophosphate;
c. from 0.01% to 5% of calcium peroxide; and d. from 80% to 98% of one or more aqueous carriers;
wherein the oral composition has a neat pH of from 9.0 to 10.5 and a total water content of from 9.1% to 20%.
a. a soluble fluoride source capable of providing from 50 ppm to 3500 ppm of free fluoride ions;
b. an amount of at least 1.5% tetrasodium pyrophosphate;
c. from 0.01% to 5% of calcium peroxide; and d. from 80% to 98% of one or more aqueous carriers;
wherein the oral composition has a neat pH of from 9.0 to 10.5 and a total water content of from 9.1% to 20%.
2. The oral composition according to Claim 1 wherein the soluble fluoride source is sodium fluoride.
3. The oral composition according to any of the preceding claims wherein the composition comprises from 1.5% to 15% tetrasodium pyrophosphate of which some or all of the tetrasodium pyrophosphate is undissolved in the product and is present as tetrasodium pyrophosphate particles.
4. The oral composition according to any of the preceding claims wherein the calcium peroxide is in an amount of from 0.1% to 3.0%.
5. The oral composition according to any of the preceding claims wherein the neat pH is from 9.2 to 10.2.
6. The oral composition according to any of the preceding claims where the total water content is from 9.2% to 14%.
7. The oral composition according to any of the preceding claims wherein the composition is a multilayer composition which is extruded from a tube in combination paste/gel stripes.
8. The oral composition according to any of the preceding claims wherein the composition further comprises from 0.5% to 40% of an alkali metal bicarbonate salt.
9. The oral composition according to any of the preceding claims further comprising from 0.01% to 25% of xylitol.
10. The oral composition comprising a soluble fluoride source capable of providing from 50 ppm to 3500 ppm of free fluoride ions; an amount of at least 1.5%
tetrasodium pyrophosphate; from 0.01% to 5% of calcium peroxide; and from 80% to 98% of one or more aqueous carriers;
wherein the oral composition has a neat pH of from 9.0 to 10.5 and a total water content of from 9.1% to 20%, produced according to a process comprising the steps of:
a. preparing a mixture of a soluble fluoride source and one or more aqueous carrier materials;
b. adding tetrasodium pyrophosphate and calcium peroxide, all at once or in portions, under conditions wherein less than 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture, and wherein any further remaining aqueous carrier materials not added to the mixtures during step (a) are added in whole or in part in step (b) or thereafter, either by themselves or with any remaining amount of the tetrasodium pyrophosphate or calcium peroxide under conditions such that less than 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture; and c. heating the mixture to a temperature range of from 38° C to 71° C.
tetrasodium pyrophosphate; from 0.01% to 5% of calcium peroxide; and from 80% to 98% of one or more aqueous carriers;
wherein the oral composition has a neat pH of from 9.0 to 10.5 and a total water content of from 9.1% to 20%, produced according to a process comprising the steps of:
a. preparing a mixture of a soluble fluoride source and one or more aqueous carrier materials;
b. adding tetrasodium pyrophosphate and calcium peroxide, all at once or in portions, under conditions wherein less than 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture, and wherein any further remaining aqueous carrier materials not added to the mixtures during step (a) are added in whole or in part in step (b) or thereafter, either by themselves or with any remaining amount of the tetrasodium pyrophosphate or calcium peroxide under conditions such that less than 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture; and c. heating the mixture to a temperature range of from 38° C to 71° C.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/756,740 US5820852A (en) | 1996-11-26 | 1996-11-26 | Oral compositions containing fluoride, pyrophosphate, and peroxide |
| US08/756,740 | 1996-11-26 | ||
| PCT/US1997/021151 WO1998023248A1 (en) | 1996-11-26 | 1997-11-19 | Oral compositions containing fluoride, pyrophosphate, and peroxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2271796A1 true CA2271796A1 (en) | 1998-06-04 |
Family
ID=25044853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002271796A Abandoned CA2271796A1 (en) | 1996-11-26 | 1997-11-19 | Oral compositions containing fluoride, pyrophosphate, and peroxide |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5820852A (en) |
| EP (1) | EP0941048A1 (en) |
| CN (1) | CN1238674A (en) |
| CA (1) | CA2271796A1 (en) |
| WO (1) | WO1998023248A1 (en) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69324678T2 (en) * | 1992-11-27 | 1999-12-09 | Naamloze Vennootschap Innogenetics S.A., Gent | METHOD FOR TYPING HCV ISOLATES |
| US5885556A (en) * | 1996-01-11 | 1999-03-23 | The Procter & Gamble Company | Tartar control oral compositions |
| US5958381A (en) * | 1998-03-12 | 1999-09-28 | Colgate Palmolive Company | Bis-biguanide antiplaque dentifrice exhibiting reduced staining |
| US6110446A (en) * | 1998-10-05 | 2000-08-29 | Colgate Palmolive Company | Dual component antiplaque and tooth whitening composition |
| US5997301A (en) * | 1998-10-20 | 1999-12-07 | Linden; Lars Ake | Treatment of tooth surfaces and substances therefor |
| US5915969A (en) * | 1998-10-20 | 1999-06-29 | Linden; Lars Aake | Treatment of tooth surfaces and substance therefor |
| US6238648B1 (en) * | 1999-03-25 | 2001-05-29 | The Procter & Gamble Company | Anti-caries oral care compositions and their methods of use |
| ATE421894T1 (en) | 2000-03-17 | 2009-02-15 | Lg Household & Health Care Ltd | PLASTER FOR WHITENING TEETH |
| US8652446B2 (en) | 2000-03-17 | 2014-02-18 | Lg Household & Healthcare Ltd. | Apparatus and method for whitening teeth |
| US6689344B2 (en) | 2000-03-17 | 2004-02-10 | Lg Household & Healthcare Ltd. | Patches for teeth whitening |
| US7785572B2 (en) | 2000-03-17 | 2010-08-31 | Lg Household And Health Care Ltd. | Method and device for teeth whitening using a dry type adhesive |
| US6517350B2 (en) | 2000-05-26 | 2003-02-11 | Dentovations Inc. | Method for whitening teeth |
| WO2002021931A1 (en) | 2000-09-12 | 2002-03-21 | Wm. Wrigley Jr. Company | Chewing gum formulations including encapsulated aspartame and sodium pyrophosphate |
| US6818150B2 (en) * | 2000-12-22 | 2004-11-16 | Chevron Phillips Chemical Company Lp | UV- or heat-triggered low oxygen packaging system employing an oxidizable polymer resin and a peroxide |
| US6946142B2 (en) | 2001-06-23 | 2005-09-20 | Lg Household & Healthcare Ltd. | Multi-layer patches for teeth whitening |
| US7196183B2 (en) * | 2001-08-31 | 2007-03-27 | Innogenetics N.V. | Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| US20060141422A1 (en) * | 2004-04-20 | 2006-06-29 | K Philp Graham Jr | Method and apparatus for tooth whitening |
| AU2003243392B2 (en) * | 2003-06-05 | 2010-07-01 | French Transit, Llc | Method for whitening teeth |
| ES2596753T3 (en) * | 2003-08-29 | 2017-01-11 | Fujirebio Europe N.V. | New clade of the hepatitis C virus and prototype sequences thereof |
| US20050255054A1 (en) * | 2004-04-30 | 2005-11-17 | Philp Graham K Jr | Method for tooth whitening, in particular a system for tooth whitening using a dissolvable tray or strip |
| US7846411B2 (en) * | 2004-06-17 | 2010-12-07 | Ada Foundation | Calcium peroxyphosphates and use thereof in dental compositions |
| US20060110340A1 (en) * | 2004-11-24 | 2006-05-25 | American Dental Association Foundation | Compositions and methods for whitening, mineralizing and/or fluoridating calcified tissues |
| US7504045B2 (en) * | 2005-06-07 | 2009-03-17 | Cryovac, Inc. | Method of triggering a film containing an oxygen scavenger |
| US20070190090A1 (en) * | 2006-02-07 | 2007-08-16 | Whitehill Oral Technologies, Inc. | Sialagogue based oral care products |
| WO2008045076A1 (en) * | 2006-10-12 | 2008-04-17 | Dentovations Inc. | Moldable tray, system, and method for whitening teeth |
| WO2008147997A1 (en) * | 2007-05-24 | 2008-12-04 | Ada Foundation | Tooth fluoridating and remineralizing compositions and methods, based on nanoaggregate formation |
| US20090226549A1 (en) | 2008-03-06 | 2009-09-10 | Kenneth John Hughes | Herbal extracts and flavor systems for oral products and methods of making the same |
| WO2011160996A1 (en) * | 2010-06-23 | 2011-12-29 | Unilever Plc | Non-aqueous oral care compositions |
| WO2012092572A2 (en) | 2010-12-30 | 2012-07-05 | Dentovations Inc. | Method and device for whitening teeth using sonochemistry |
| WO2013055478A1 (en) * | 2011-10-10 | 2013-04-18 | Ultradent Products, Inc | Anti-plaque dental compositions |
| JP2015508488A (en) * | 2011-12-21 | 2015-03-19 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Hot and salivary immunoglobulin |
| US9333154B2 (en) * | 2012-01-12 | 2016-05-10 | M & O Solutions, Llc | Dual component oral composition for enhancing remineralization of teeth |
| ITMI20120883A1 (en) | 2012-05-22 | 2013-11-23 | Brux S R L | NEW FORMULATION FOR THE PREVENTION OF DENTAL CARIES |
| AU2012396805B2 (en) | 2012-12-14 | 2015-08-20 | Colgate-Palmolive Company | Peroxide-stable oral care compositions |
| BR112016025868B1 (en) | 2014-05-15 | 2020-06-30 | The Procter & Gamble Company | oral treatment compositions containing polyethylene glycol for physical stability and method for treating dental enamel |
| US12102499B2 (en) * | 2018-06-06 | 2024-10-01 | Solventum Intellectual Properties Company | Two-part dental sealant, method of applying with a syringe device, and kit |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925655A (en) * | 1988-03-04 | 1990-05-15 | Robell Research | Powder composition for forming a mouthwash |
| US5424059A (en) * | 1988-12-29 | 1995-06-13 | Colgate Palmolive Company | Antibacterial antiplaque dentifrice |
| US5256402A (en) * | 1991-09-13 | 1993-10-26 | Colgate-Palmolive Company | Abrasive tooth whitening dentifrice of improved stability |
| US5292502A (en) * | 1992-07-02 | 1994-03-08 | Colgate-Palmolive Co. | Non-irritating dentifrice |
| US5496541C1 (en) * | 1993-01-19 | 2001-06-26 | Squigle Inc | Tasteful toothpaste and other dental products |
| US5302374A (en) * | 1993-04-21 | 1994-04-12 | Dental Concepts Inc. | Oral hygiene system |
| JPH09500101A (en) * | 1993-04-23 | 1997-01-07 | ザ、プロクター、エンド、ギャンブル、カンパニー | Method for producing tartar control baking soda dentifrice |
| US5296215A (en) * | 1993-06-16 | 1994-03-22 | Colgate-Palmolive Company | High foaming rheologically stable non-irritating oral composition |
| US5372803A (en) * | 1993-09-02 | 1994-12-13 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Dental compositions with zinc and bicarbonate salts |
| US5403578A (en) * | 1994-02-08 | 1995-04-04 | Gordon; Norman | Stable tooth and gum dentifrice with microencapsulation and method for making same |
| US5571501A (en) * | 1994-03-15 | 1996-11-05 | Colgate Palmolive Company | Antibacterial oral care composition containing triclosan of improved compatibility |
| US5565190A (en) * | 1994-11-14 | 1996-10-15 | Colgate Palmolive Company | Dentifrice compositions containing reactive ingredients stabilized with alkali metal compounds |
| US5599525A (en) * | 1994-11-14 | 1997-02-04 | Colgate Palmolive Company | Stabilized dentifrice compositions containing reactive ingredients |
| US5599527A (en) * | 1994-11-14 | 1997-02-04 | Colgate-Palmolive Company | Dentifrice compositions having improved anticalculus properties |
| US5614174A (en) * | 1994-11-14 | 1997-03-25 | Colgate Palmolive Company | Stabilized dentifrice compositions containing reactive ingredients |
| US5624906A (en) * | 1994-12-08 | 1997-04-29 | Lever Brothers Company, Division Of Conopco, Inc. | Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds |
| PT918698E (en) * | 1996-06-06 | 2002-04-29 | Colgate Palmolive Co | CO-DISTRIBUTION OF PHYSICALLY SEGRAGED DENTIFICTS AT CONSISTENT REASONS |
-
1996
- 1996-11-26 US US08/756,740 patent/US5820852A/en not_active Expired - Fee Related
-
1997
- 1997-11-19 EP EP97949487A patent/EP0941048A1/en not_active Withdrawn
- 1997-11-19 CN CN97180029.4A patent/CN1238674A/en active Pending
- 1997-11-19 WO PCT/US1997/021151 patent/WO1998023248A1/en not_active Application Discontinuation
- 1997-11-19 CA CA002271796A patent/CA2271796A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1238674A (en) | 1999-12-15 |
| WO1998023248A1 (en) | 1998-06-04 |
| EP0941048A1 (en) | 1999-09-15 |
| US5820852A (en) | 1998-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5820852A (en) | Oral compositions containing fluoride, pyrophosphate, and peroxide | |
| US5849269A (en) | Oral compositions containing fluoride, pyrophosphate, peroxide, and nonionic and/or amphoteric surfactants | |
| US5885553A (en) | Hydrophobic agents for use in oral care products | |
| US5885554A (en) | Hydrophobic agents and polymeric surfactants | |
| CA2271842C (en) | Flavor systems for oral care products | |
| CA2271302C (en) | Dentifrice compositions containing polyphosphate and fluoride | |
| CA2271420C (en) | Dentifrice compositions containing polyphosphate and monofluorophosphate | |
| US5820854A (en) | Oral compositions containing polyoxyethylene | |
| US5811080A (en) | Process for increased flavor impact in oral care products | |
| US5820853A (en) | Oral compositions forming a coacervate gel | |
| CA2401752A1 (en) | Stable dentrifice compositions comprising polyphosphate, fluoride, and stannous | |
| US5939080A (en) | Hydrophobic agents and non-polymeric surfactants use in oral care products | |
| US5776437A (en) | Method of making a tartar control dentifrice containing fluoride and peroxide | |
| CA2348892C (en) | Method of reducing staining of stannous in dentifrice compositions | |
| US5885556A (en) | Tartar control oral compositions | |
| WO1998043603A1 (en) | Dual phase oral compositions containing a basic phase and an acidic phase | |
| HK1023502B (en) | Dentifrice compositions containing polyphosphate and fluoride | |
| HUP9903532A2 (en) | Dentifrice composition containing polyphosphate and fluoride as active ingredient in two detached compositions | |
| MXPA01005399A (en) | Method of reducing staining of stannous in dentifrice compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |